UniSuper Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Sell
7,621
-2,301
-23% -$605K 0.01% 414
2026
Q1
$2.65M Sell
9,922
-506
-5% -$137K 0.02% 399
2025
Q4
$2.62M Sell
10,428
-1,461
-12% -$388K 0.02% 409
2025
Q3
$3.41M Buy
11,889
+1,841
+18% +$493K 0.02% 363
2025
Q2
$2.64M Sell
10,048
-200
-2% -$48.7K 0.02% 402
2025
Q1
$2.39M Sell
10,248
-240
-2% -$58.2K 0.02% 415
2024
Q4
$2.41M Buy
10,488
+1,519
+17% +$348K 0.02% 399
2024
Q3
$2M Sell
8,969
-40,309
-82% -$8.86M 0.02% 437
2024
Q2
$10M Buy
49,278
+3,218
+7% +$655K 0.08% 147
2024
Q1
$10.1M Buy
46,060
+4,248
+10% +$936K 0.1% 137
2023
Q4
$9.5M Sell
41,812
-407
-1% -$85.5K 0.11% 138
2023
Q3
$8.49M Sell
42,219
-7,085
-14% -$1.49M 0.1% 139
2023
Q2
$10.2M Buy
+49,304
New +$9.56M 0.12% 130

Other funds holding LH

UniSuper Management's LH Position: Q2 2026 in Review

UniSuper Management reduced its Labcorp (LH) stake by 23% in Q2 2026, selling an estimated $605K and leaving 7,621 shares worth $2.13M. The position accounts for 0.01% of the portfolio, ranked #414.

UniSuper Management first reported a position in LH in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.2M in Q2 2023. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • UniSuper Management held 7,621 shares of Labcorp worth $2.13M as of Q2 2026.
  • UniSuper Management sold 2,301 Labcorp shares in Q2 2026, an estimated $605K.
  • Labcorp made up 0.01% of UniSuper Management's portfolio in Q2 2026, its #414 holding.
  • UniSuper Management first reported a position in Labcorp in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Labcorp position peaked at $10.2M in Q2 2023.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.